National University Hospital, Singapore
Assoc. Prof. Edmund Chiong, MBBS, PhD, FRCSEd, FRCSI, FAMS (Urology), is presently the Head and Senior Consultant of the Department of Urology, National University Hospital, Singapore. He is also an Associate Professor at the National University of Singapore (NUS) and a Senior Consultant in the Division of Surgical Oncology, National University Cancer Institute, Singapore. Assoc. Prof. Chiong graduated with the degrees of Bachelor of Medicine and Surgery from the National University of Singapore in 1995. He obtained postgraduate qualifications (Fellow of the Royal College of Surgeons of Edinburgh and Fellow of the Royal College of Surgeons In Ireland) in Surgery (in 2000) and completed of his Urology specialist training in Singapore. Assoc. Prof. Chiong subsequently underwent a 2-year clinical fellowship program in Urologic Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA. His sub-specialty interest is in Urologic Oncology and performing DaVinci robotic surgery. His research interests include investigating immunotherapy, gene therapy and targeted therapy for bladder cancer, and diagnostic modalities and new therapies for urologic malignancies. He has minor interests in investigating urinary tract infections, and medical device innovation. He was conferred a PhD (NUS) for his thesis on targeted therapy for bladder cancer. He also runs a number of clinical trials in bladder and prostate cancer. Assoc. Prof. Chiong is currently the Immediate Past President of the Singapore Urological Association (2016-2018), Vice Chairman of the Chapter of Urologists (College of Surgeons), Academy of Medicine, Singapore, and the Chairman of the Examinations Committee for Urology and Board member, Residency Advisory Committee / Joint Committee on Specialist Training (JCST), Ministry of Health, Singapore. He is also the Deputy Chairman, Scientific Committee, Urological Association of Asia (UAA), a member of the American Urological Association, European Association of Urology and the American Society of Clinical Oncology.
Disclosure information not submitted.
Friday, April 28, 2023
3:30 PM – 5:30 PM CST